This is exemplified by our own findings that tumoral KYNU, but not IDO1, is selectively and frequently upregulated in NRF2 activated tumors and that elevated tumoral KYNU is associated with high immune cell infiltration across several cancer types (22, 23). The gene discussed is IDO1; the disease is cancer.